2024-11-22 |
2024-11-21 |
B
Purchase
|
Riley Antony A
CHIEF FINANCIAL OFFICER
Officer
|
22,514
+272.5%
5.55
USD 124,998
|
22,514
+272.5%
|
5.55
|
USD 124,998
|
|
2023-12-20 |
2023-12-18 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
10,000
+0.6%
0.75
USD 7,525
|
10,000
+0.6%
|
0.75
|
USD 7,525
|
|
2023-12-15 |
2023-12-14 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
10,000
+0.6%
0.72
USD 7,200
|
10,000
+0.6%
|
0.72
|
USD 7,200
|
|
2023-12-15 |
2023-12-13 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
10,520
+0.6%
0.70
USD 7,351
|
10,520
+0.6%
|
0.70
|
USD 7,351
|
|
2023-12-12 |
2023-12-12 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
4,776
+0.3%
0.65
USD 3,088
|
4,776
+0.3%
|
0.65
|
USD 3,088
|
|
2023-12-12 |
2023-12-11 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
25,000
+1.4%
0.65
USD 16,188
|
25,000
+1.4%
|
0.65
|
USD 16,188
|
|
2023-12-08 |
2023-12-08 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
15,000
+0.9%
0.62
USD 9,300
|
15,000
+0.9%
|
0.62
|
USD 9,300
|
|
2023-12-08 |
2023-12-07 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
36,203
+2.1%
0.58
USD 21,168
|
36,203
+2.1%
|
0.58
|
USD 21,168
|
|
2023-11-22 |
2023-11-22 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
400
+0.0%
0.43
USD 172
|
400
+0.0%
|
0.43
|
USD 172
|
|
2023-11-22 |
2023-11-20 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
100
+0.0%
0.43
USD 43
|
100
+0.0%
|
0.43
|
USD 43
|
|
2023-11-22 |
2023-11-20 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
1,566
+0.1%
0.43
USD 673
|
1,566
+0.1%
|
0.43
|
USD 673
|
|
2023-11-22 |
2023-11-20 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
5,300
+0.3%
0.44
USD 2,332
|
5,300
+0.3%
|
0.44
|
USD 2,332
|
|
2022-12-19 |
2022-12-16 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
44,024
+3.3%
1.07
USD 47,000
|
44,024
+3.3%
|
1.07
|
USD 47,000
|
|
2022-12-19 |
2022-12-15 |
B
Purchase
|
Wagner Paul A.
See Remarks
Executive Director
|
55,976
+4.4%
1.03
USD 57,672
|
55,976
+4.4%
|
1.03
|
USD 57,672
|
|
2020-04-14 |
2020-04-14 |
B
Purchase
|
Oliveira Steven Michael
Large shareholder
|
74,301
+2.7%
1.19
USD 88,418
|
74,301
+2.7%
|
1.19
|
USD 88,418
|
|
2020-03-03 |
2020-03-02 |
B
Purchase
|
Oliveira Steven Michael
Large shareholder
|
65,149
+2.4%
1.35
USD 87,756
|
65,149
+2.4%
|
1.35
|
USD 87,756
|
|
2019-06-03 |
2019-05-30 |
B
Purchase
|
Hasnain Faheem
|
250
+0.1%
5.15
USD 1,287
|
250
+0.1%
|
5.15
|
USD 1,287
|
|
2019-06-03 |
2019-05-30 |
B
Purchase
|
Hasnain Faheem
|
3,890
+1.6%
5.30
USD 20,613
|
3,890
+1.6%
|
5.30
|
USD 20,613
|
|
2019-06-03 |
2019-05-30 |
B
Purchase
|
Hasnain Faheem
|
38,860
+19.2%
4.59
USD 178,414
|
38,860
+19.2%
|
4.59
|
USD 178,414
|
|
2019-05-29 |
2019-05-28 |
PP
Planned purchase
|
Duvall Martin J
Chief Executive Officer
Executive Director
|
5,000
+58.1%
4.34
USD 21,679
|
5,000
+58.1%
|
4.34
|
USD 21,679
|
|
2019-05-29 |
2019-05-28 |
PP
Planned purchase
|
FOLETTA MARK G
EVP & Chief Financial Officer
Officer
|
5,000
+49.8%
4.30
USD 21,475
|
5,000
+49.8%
|
4.30
|
USD 21,475
|
|
2019-05-29 |
2019-05-24 |
PP
Planned purchase
|
GRUBER HARRY E
President, Science&Innovation
Executive Director
|
5,000
+105.4%
4.56
USD 22,783
|
5,000
+105.4%
|
4.56
|
USD 22,783
|
|
2017-04-21 |
2017-04-19 |
B
Purchase
|
Das Asha
SVP & Chief Medical Officer
|
2,500
+inf%
10.00
USD 25,000
|
2,500
+inf%
|
10.00
|
USD 25,000
|
|
2017-04-21 |
2017-04-19 |
B
Purchase
|
SCHIMMEL PAUL
|
10,000
+276.0%
10.00
USD 100,000
|
10,000
+276.0%
|
10.00
|
USD 100,000
|
|
2017-04-21 |
2017-04-19 |
B
Purchase
|
GRUBER HARRY E
President, Research & Devel
Executive Director
|
25,000
+6.4%
10.00
USD 250,000
|
25,000
+6.4%
|
10.00
|
USD 250,000
|
|
2017-04-21 |
2017-04-19 |
B
Purchase
|
FOLETTA MARK G
EVP & Chief Financial Officer
|
5,000
+inf%
10.00
USD 50,000
|
5,000
+inf%
|
10.00
|
USD 50,000
|
|
2017-04-21 |
2017-04-19 |
B
Purchase
|
Hasnain Faheem
|
100,000
+97.2%
10.00
USD 1,000,000
|
100,000
+97.2%
|
10.00
|
USD 1,000,000
|
|